- TOP
- Investors
- Management
- CEO Message
CEO Message
Thank you for your continued support of the Nissha Group.
Overview of consolidated financial results
for the fiscal year ended December 31, 2024
During the fiscal year ended December 31, 2024, the global economy trended toward recovery. In the United States, the economy expanded as consumer spending and other factors remained firm. In Europe, the economy came to a temporary standstill as production activities slowed down due to sluggish foreign demand, etc. In China, a weak economy continued against a backdrop of the real estate slump and other factors. Meanwhile, the Japanese economy recovered moderately due to firm capital investments, among other factors.
Under these conditions, during the fiscal year ended December 31, 2024, product demand in the field of decorations in the Industrial Materials segment remained firm, and we saw a recovery in demand for products, such as sustainable materials in the Industrial Materials segment and products for tablets and handheld terminals (logistics related) in the Devices segment, which had been sluggish in the previous fiscal year. In the Medical Technologies segment, the acquisition of companies has begun to contribute to earnings, while product demand remained firm.
As a result, regarding the financial results for the fiscal year ended December 31, 2024, net sales were ¥195,598 million (an increase of 16.6% as compared to the previous year), operating profit was ¥5,486 million (operating loss of ¥3,817 million in the previous year) and profit attributable to owners of parent was ¥3,862 million (loss attributable to owners of parent of ¥2,988 million in the previous year).
Plan for the fiscal year ending December 31, 2025
Under these conditions, the Industrial Materials segment plans to respond to firm product demand in the existing fields, while starting to supply new products for mobility exterior components. In addition, we project a steady rise in demand for our main field of contract design/development manufacturing services for medical devices in the Medical Technologies segment, and a contribution to our financial results from the company that we decided to acquire in the fiscal year ended December 31, 2024 in Other segment. Meanwhile, we expect product demand for tablets in the Devices segment to decline due to changes in the product mix, etc. Therefore, we will pursue higher productivity and efficiency by reviewing our production structure in this segment.
As these results, for the consolidated financial results for the fiscal year ending December 31, 2025, we expect net sales of ¥190,800 million, operating profit of ¥6,600 million, profit before tax of ¥5,700 million and profit attributable to owners of parent of ¥4,000 million. These figures are based on an exchange rate of 1US$ = ¥140 for the fiscal year ending December 31, 2025.
| 2024 Results |
2025 Plan |
|
|---|---|---|
|
Net sales （Millions of JPY） |
195,598 | 190,800 |
|
Operating profit （Millions of JPY） |
5,486 | 6,600 |
|
Profit before tax （Millions of JPY） |
6,213 | 5,700 |
|
Profit attributable to owners of parent （Millions of JPY） |
3,862 | 4,000 |
In Conclusion
Once again, I want to thank you, our shareholders and investors, for your support to the Nissha Group.
Junya Suzuki
Chairman of the Board and Group CEO
